What is CVE-2025-1888?

CVE-2025-1888 is a medium-severity vulnerability in Leica Biosystems Aperio Eslide Manager, classified under Cross-site Scripting. CVSS score: 4.6/10. Published 2025-03-14.

How severe is CVE-2025-1888?

Medium severity. CVSS v3 base score is 4.6 out of 10.

XSS in Leica Biosystems Aperio Eslide Manager

CVE-2025-1888

The Leica Web Viewer within the Aperio Eslide Manager Application is vulnerable to reflected cross-site scripting (XSS). An authenticated user can access the slides within a project and injecting malicious JavaScript into the "memo" field…

Vulnerability class: XSS (Cross-Site Scripting)

EPSS: 0.002 (11.1th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 4.6 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:L/I:L/A:N.

Affected products

Leica Biosystems Aperio Eslide Manager — versions 12.3.2.5030

Weakness classification (CWE)

CWE-79 — Cross-site Scripting

References

cves@blacklanternsecurity.com (technical-description)

Frequently asked questions

What is CVE-2025-1888?: CVE-2025-1888 is a medium-severity vulnerability in Leica Biosystems Aperio Eslide Manager, classified under Cross-site Scripting. CVSS score: 4.6/10. Published 2025-03-14.
How severe is CVE-2025-1888?: Medium severity. CVSS v3 base score is 4.6 out of 10.